Ben Bernanke Joins Anthropic's Long-Term Benefit Trust

Dr. Ben Bernanke — Fed chair from 2006 to 2014, 2022 Nobel laureate in economics, now a Distinguished Fellow at Brookings — has joined Anthropic's Long-Term Benefit Trust (LTBT). He becomes the fourth trustee, and a fifth is planned. His mandate leans into the question Anthropic studies most: how AI is reshaping the economy and the labor market — the area where a former central banker's read on jobs, wages and growth carries the most weight. In his appointment statement, Bernanke said how AI's potential plays out "will depend, in part, on the institutions we build around it."

Bernanke joins three existing trustees, each brought in for a distinct lens on Anthropic's mission:

The LTBT is a September-2023 Delaware purpose trust. It holds a special stock class — Class T shares — that lets trustees elect a growing share of Anthropic's board over time, aiming for majority control within four years of formation. Trustees are independent: no equity, no profit share, paid only for their time. In plain terms, the trust can eventually outvote shareholders if it judges the company is drifting from its safety mission.

The timing is the story. The appointment lands as Anthropic reportedly filed confidentially for an IPO — a target as soon as ~October 2026 at a roughly $965B valuation, per Bloomberg. So a former central banker is joining the oversight body just as the company heads to public markets, where independent trustees and investors will share the room.

Watch the mechanism, not the name. The LTBT's leverage rests on the Class T shares and the four-year path to a board majority — a marquee economist adds credibility, but the teeth are structural. As Anthropic moves toward public markets, whether that independent oversight holds up against shareholder pressure is the real test, and the fifth trustee seat is still open.